Find out more about enrolling in a clinical trial at Profil Institute for Clinical Research, Inc., a division of ProSciento, Inc.
Thank you for your interest in finding out more about participation in a clinical trial at Profil Institute for Clinical Research, Inc.
Our clinical study participants play a very important role in finding new, better treatments for diabetes and obesity. Study participants range from people who are diagnosed with Type 1 or Type 2 diabetes, to people who are overweight or have high cholesterol, to people who are diagnosed with NAFLD or NASH, and even to people who are healthy and have no symptoms of diabetes or obesity.
In cooperation with the pharmaceutical industry and academic centers, we perform clinical studies for the development and testing of new drugs and medical devices to treat diabetes, obesity and cardiometabolic diseases. This includes examining the effectiveness and safety of new investigational medicines, diagnostics, and new methods of administering existing therapeutics, such as insulin that can be inhaled.
If you have any further questions, please contact us using email or calling us at +1 (866) 308-7427.